ペニシリン結合タンパク質の活性部位内のボロン酸の予期せぬ三価結合方式
Astrid Zervosen1, Raphael Herman, Frédéric Kerff
1Centre de Recherches du Cyclotron, Université de Liège, B-4000 Sart Tilman, Liège, Belgium.
Journal of the American Chemical Society
|May 18, 2011
まとめ
ボロン酸は意外にペニシリン結合タンパク質R39と三重結合アダクトを形成し,新しい酵素阻害機構を明らかにした. この発見は,セリンアミドヒドロラゼ抑制と薬物設計に関する新しい洞察を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 酵素阻害は酵素を阻害する.
背景:
- ボロン酸は,セリンアミドヒドロラーゼの阻害剤として知られており,通常,酵素の移行状態を模倣する四面体添加物を形成します.
- ペニシリン結合タンパク質 (PBP) は,アクティノマドゥラ種 (Actinomadura sp.) のDD-ペプチダゼのようなものです. R39は,抗菌研究における重要な標的である.
研究 の 目的:
- 新型アミドメチルボロン酸によるDD-ペプチダースR39の抑制の構造的基礎を解明する.
- 酵素阻害剤アダクトの形成とその触媒機構への影響について調査する.
主な方法:
- X線結晶学を用いて,4つのアミドメチルボロン酸とボロン酸ピナコールエステルで複合したDD-ペプチダースR39の構造を解明した.
- DD-ペプチダースR39と2,6-ジメトキシベンザミドメチルボロン酸の反応を分析するために,運動学的研究が行われました.
主要な成果:
- この研究では,ボロンが3つの活性部位残留物 (Ser49,Ser298,Lys410) と相互作用する最初の結晶学的に観察された三重対価酵素阻害剤アダクトが特定されました.
- いくつかのケースでは,同じ結晶構造の中で三重和性および一重和性アダクトの両方が観察され,ダイナミックな結合プロセスを示唆しました.
- 双相運動が観察されましたが,三相相複合体の形成と直接相関していません.
結論:
- アミドメチルボロン酸は,予期せぬトリコヴァレンントアダクト形成を通じてDD-ペプチダースR39を阻害し,セリンアミドヒドローラゼ抑制の既知のモードを拡張します.
- この発見は,この新しい阻害経路の詳細な構造とメカニズムを理解し,潜在的に新しい治療薬の設計を導くことができます.
関連する概念動画
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:42Valence Bond Theory
Coordination compounds and complexes exhibit different colors, geometries, and magnetic behavior, depending on the metal atom/ion and ligands from which they are composed. In an attempt to explain the bonding and structure of coordination complexes, Linus Pauling proposed the valence bond theory, or VBT, using the concepts of hybridization and the overlapping of the atomic orbitals. According to VBT, the central metal atom or ion (Lewis acid) hybridizes to provide empty orbitals of suitable...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...